Speaking to CNBC-TV18, Kiran Mazumdar Shaw, chairman and ,managing director of Biocon said," I am glad that NPPA has given us this price increase. It still puts us at a discount to other multinationals and importers of insulin but at least one step at a time."
first published: Mar 17, 2011 05:10 pm
A collection of the most-viewed Moneycontrol videos.
